Fabiola Porro
Trieste, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
CRISPR-Cas9-mediated somatic correction of a one-base deletion in the Ugt1a gene ameliorates hyperbilirubinemia in Crigler-Najjar syndrome mice.
Journal: Molecular therapy. Methods & clinical development
Published: February 10, 2023
Promoterless Gene Targeting Approach Combined to CRISPR/Cas9 Efficiently Corrects Hemophilia B Phenotype in Neonatal Mice.
Journal: Frontiers in genome editing
Published: September 29, 2021
Bone strain index reproducibility and soft tissue thickness influence: a dual x-ray photon absorptiometry phantom study.
Journal: European radiology experimental
Published: February 22, 2019
Promoterless gene targeting without nucleases rescues lethality of a Crigler-Najjar syndrome mouse model.
Journal: EMBO molecular medicine
Published: July 29, 2017
TDP-43 regulates β-adducin (Add2) transcript stability.
Journal: RNA biology
Published: January 21, 2015
Generation of Ugt1-deficient murine liver cell lines using TALEN technology.
Journal: PloS one
Published: April 14, 2014
Long-distance regulation of Add2 pre-mRNA3'end processing.
Journal: RNA biology
Published: February 16, 2013
Characterization of the distal polyadenylation site of the ß-adducin (Add2) pre-mRNA.
Journal: PloS one
Published: November 14, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026